BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 179 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,826 | +138904.3% | 27,094 | +96.3% | 0.00% | 0.0% |
| Q4 2022 | $138 | -99.9% | 13,805 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $190,000 | +15.9% | 13,805 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $164,000 | +18.0% | 13,805 | +2.3% | 0.00% | 0.0% |
| Q1 2022 | $139,000 | -29.8% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $198,000 | 0.0% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $198,000 | -24.4% | 13,500 | -26.7% | 0.00% | -50.0% |
| Q2 2021 | $262,000 | +14.4% | 18,423 | -2.3% | 0.00% | +100.0% |
| Q1 2021 | $229,000 | +27.9% | 18,857 | -3.4% | 0.00% | 0.0% |
| Q4 2020 | $179,000 | +141.9% | 19,521 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $74,000 | -20.4% | 19,906 | +3.3% | 0.00% | 0.0% |
| Q2 2020 | $93,000 | +43.1% | 19,275 | +5.7% | 0.00% | 0.0% |
| Q1 2020 | $65,000 | +27.5% | 18,239 | 0.0% | 0.00% | – |
| Q4 2019 | $51,000 | +27.5% | 18,239 | +7.9% | 0.00% | – |
| Q3 2019 | $40,000 | -32.2% | 16,906 | -0.3% | 0.00% | – |
| Q2 2019 | $59,000 | -59.9% | 16,959 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $147,000 | 0.0% | 16,959 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $147,000 | +23.5% | 16,959 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $119,000 | +10.2% | 16,959 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $108,000 | +31.7% | 16,959 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $82,000 | -1.2% | 16,959 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $83,000 | +13.7% | 16,959 | +3.3% | 0.00% | 0.0% |
| Q3 2017 | $73,000 | -14.1% | 16,421 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $85,000 | -18.3% | 16,421 | +2.0% | 0.00% | 0.0% |
| Q1 2017 | $104,000 | +4.0% | 16,105 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $100,000 | +66.7% | 16,105 | +18.8% | 0.00% | 0.0% |
| Q3 2016 | $60,000 | -10.4% | 13,553 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $67,000 | +59.5% | 13,553 | 0.0% | 0.00% | – |
| Q1 2016 | $42,000 | -63.5% | 13,553 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $115,000 | -27.2% | 13,553 | -2.1% | 0.00% | 0.0% |
| Q3 2015 | $158,000 | -62.0% | 13,847 | -50.1% | 0.00% | -50.0% |
| Q2 2015 | $416,000 | +232.8% | 27,766 | +100.0% | 0.00% | +100.0% |
| Q1 2015 | $125,000 | -63.0% | 13,883 | -50.0% | 0.00% | 0.0% |
| Q4 2014 | $338,000 | +148.5% | 27,766 | +100.0% | 0.00% | 0.0% |
| Q3 2014 | $136,000 | -26.9% | 13,883 | -4.8% | 0.00% | -50.0% |
| Q2 2014 | $186,000 | +30.1% | 14,589 | +8.1% | 0.00% | +100.0% |
| Q1 2014 | $143,000 | +38.8% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $103,000 | -47.7% | 13,500 | -50.0% | 0.00% | 0.0% |
| Q3 2013 | $197,000 | +302.0% | 27,000 | -14.8% | 0.00% | – |
| Q2 2013 | $49,000 | – | 31,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |